OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 122 filers reported holding OCULAR THERAPEUTIX INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $179,187 | -63.5% | 57,066 | -40.0% | 0.00% | – |
Q2 2023 | $490,737 | +39.4% | 95,104 | +42.4% | 0.00% | – |
Q1 2023 | $351,936 | +27.8% | 66,781 | -31.9% | 0.00% | – |
Q4 2022 | $275,408 | +14.8% | 98,010 | +68.9% | 0.00% | – |
Q3 2022 | $240,000 | +51.9% | 58,035 | +47.6% | 0.00% | – |
Q2 2022 | $158,000 | -35.8% | 39,311 | -20.7% | 0.00% | – |
Q1 2022 | $246,000 | -57.5% | 49,571 | -40.4% | 0.00% | – |
Q4 2021 | $579,000 | +10.1% | 83,107 | +57.9% | 0.00% | – |
Q3 2021 | $526,000 | +2.9% | 52,644 | +46.1% | 0.00% | – |
Q2 2021 | $511,000 | -41.0% | 36,038 | -31.7% | 0.00% | – |
Q1 2021 | $866,000 | -29.8% | 52,789 | -11.4% | 0.00% | – |
Q4 2020 | $1,233,000 | +25.9% | 59,573 | -53.7% | 0.00% | – |
Q3 2020 | $979,000 | +37.5% | 128,738 | +50.4% | 0.00% | – |
Q2 2020 | $712,000 | +947.1% | 85,579 | +516.3% | 0.00% | – |
Q1 2020 | $68,000 | -5.6% | 13,887 | -23.1% | 0.00% | – |
Q4 2019 | $72,000 | +35.8% | 18,057 | +1.3% | 0.00% | – |
Q3 2019 | $53,000 | +3.9% | 17,818 | +50.3% | 0.00% | – |
Q2 2019 | $51,000 | +13.3% | 11,854 | +3.8% | 0.00% | – |
Q1 2019 | $45,000 | -57.1% | 11,419 | -56.5% | 0.00% | – |
Q4 2018 | $105,000 | +72.1% | 26,271 | +197.0% | 0.00% | – |
Q3 2018 | $61,000 | +45.2% | 8,846 | +42.0% | 0.00% | – |
Q2 2018 | $42,000 | +200.0% | 6,231 | +175.8% | 0.00% | – |
Q1 2018 | $14,000 | +16.7% | 2,259 | -15.6% | 0.00% | – |
Q4 2017 | $12,000 | +71.4% | 2,678 | +133.9% | 0.00% | – |
Q3 2017 | $7,000 | -86.3% | 1,145 | -79.3% | 0.00% | – |
Q2 2017 | $51,000 | -29.2% | 5,527 | -29.0% | 0.00% | – |
Q1 2017 | $72,000 | +7.5% | 7,782 | -2.8% | 0.00% | – |
Q4 2016 | $67,000 | +81.1% | 8,009 | +49.2% | 0.00% | – |
Q3 2016 | $37,000 | +85.0% | 5,369 | +36.8% | 0.00% | – |
Q2 2016 | $20,000 | +66.7% | 3,926 | +227.2% | 0.00% | – |
Q1 2016 | $12,000 | -70.7% | 1,200 | -72.3% | 0.00% | – |
Q4 2015 | $41,000 | +583.3% | 4,333 | +967.2% | 0.00% | – |
Q3 2015 | $6,000 | -82.9% | 406 | -75.5% | 0.00% | – |
Q2 2015 | $35,000 | +3400.0% | 1,660 | +7117.4% | 0.00% | – |
Q1 2015 | $1,000 | – | 23 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 3,804,788 | $15,105,000 | 43.34% |
Versant Venture Management, LLC | 2,215,384 | $8,795,074,000 | 2.90% |
Opaleye Management Inc. | 1,900,000 | $7,543,000 | 2.09% |
SV Health Investors, LLC | 628,236 | $2,494,000 | 1.46% |
Endurant Capital Management LP | 716,124 | $2,843,000 | 1.12% |
DELTEC ASSET MANAGEMENT LLC | 824,747 | $3,274,000 | 0.72% |
NOTTINGHAM ADVISORS, INC. | 146,946 | $583,000 | 0.08% |
Jump Trading, LLC | 39,255 | $156,000 | 0.05% |
Man Group plc | 1,723,456 | $6,842,000 | 0.03% |
JGP Global Gestao de Recursos Ltda. | 13,880 | $55,000 | 0.02% |